ArticleClinical and translational science2020

Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis.

Stéphane Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.